Merck & Co. Inc. (NYSE:MRK) is one of the best growth stocks to buy now. On October 7, Merck & Co. announced the completion ...
Quercis Pharma AG, a clinical-stage biopharmaceutical company developing inflammasome-modulating therapies in oncology, ...
As air pollution peaks this Diwali, doctors share practical ways to protect your lungs from smog-related cough, ...
AstraZeneca has now joined Pfizer in agreeing to sell its drugs to state Medicaid programs at “most-favored-nation” pricing ...
CNET's experts have tested the best air purifiers on the market for price, size and performance to help you breathe more ...
Doctors stress pollution control, routine management and emotional inclusion to ensure a safe and joyful Diwali for senior citizens ...
Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...
The respiratory medical community is moving toward shared decision-making in self-managing chronic respiratory disease, but ...
The $10 billion acquisition of Verona Pharma plc (NASDAQ:VRNA) by Merck & Co. (NYSE:MRK), which offered $107 per American ...
First deals impact Medicaid but drug makers hint they may sell all of their new drugs at most-favored-nation pricing.
President Donald Trump on Friday announced a new agreement with a major pharmaceutical manufacturer that will tie the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results